{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:53:41Z","timestamp":1793757221289,"version":"4.6.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"International Postgraduate Research Scholarship"},{"name":"NHMRC\/ARC Dementia Research Fellowship"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.arr.2018.10.005","type":"journal-article","created":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T09:21:58Z","timestamp":1540113718000},"page":"79-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Postmenopausal health interventions: Time to move on from the Women\u2019s Health Initiative?"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4891-0292","authenticated-orcid":false,"given":"Jay Jay","family":"Thaung Zaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Ranald Charles","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Heloise Xiwen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2018.10.005_bib0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/GME.0000000000000280","article-title":"Soy Isoflavones for reducing Bone Loss Study: effects of a 3-year trial on hormones, adverse events, and endometrial thickness in postmenopausal women","volume":"22","author":"Alekel","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.arr.2018.10.005_bib0010","first-page":"61","article-title":"Design of the Women\u2019s Health Initiative clinical trial and observational study","volume":"19","author":"Anderson","year":"1998","journal-title":"The Women\u2019s Health Initiative Study Group. Control Clin Trials"},{"key":"10.1016\/j.arr.2018.10.005_bib0015","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.arr.2018.10.005_bib0020","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/GME.0000000000000428","article-title":"Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)","volume":"22","author":"Archer","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.arr.2018.10.005_bib0025","series-title":"Leading Underlying Causes of Death by Sex in Australia","author":"Australian Institute of Health and Welfare","year":"2014"},{"key":"10.1016\/j.arr.2018.10.005_bib0030","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1001\/jama.1991.03460140089033","article-title":"Estrogen and coronary heart disease in women","volume":"265","author":"Barrett-Connor","year":"1991","journal-title":"Jama"},{"key":"10.1016\/j.arr.2018.10.005_bib0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF03345705","article-title":"Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women","volume":"32","author":"Basaria","year":"2009","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.arr.2018.10.005_bib0040","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1210\/jc.2009-2262","article-title":"Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes","volume":"95","author":"Bechlioulis","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.arr.2018.10.005_bib0045","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials","volume":"295","author":"Berger","year":"2006","journal-title":"Jama"},{"key":"10.1016\/j.arr.2018.10.005_bib0050","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/ajcn\/76.6.1191","article-title":"Beneficial role of dietary phytoestrogens in obesity and diabetes","volume":"76","author":"Bhathena","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.arr.2018.10.005_bib0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/13697137.2012.655564","article-title":"Evidence-based assessment of the impact of the WHI on women\u2019s health","volume":"15","author":"Burger","year":"2012","journal-title":"Climacteric"},{"issue":"2016","key":"10.1016\/j.arr.2018.10.005_bib0060","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/STROKEAHA.116.013052","article-title":"Postmenopausal hormone therapy and risk of stroke: impact of the route of estrogen administration and type of progestogen Correction","volume":"47","author":"Canonico","year":"2016","journal-title":"STROKE"},{"key":"10.1016\/j.arr.2018.10.005_bib0065","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.fertnstert.2005.09.048","article-title":"Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study","volume":"85","author":"Casini","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.arr.2018.10.005_bib0070","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jc.2014-3062","article-title":"Associations of menopausal vasomotor symptoms with fracture incidence","volume":"100","author":"Crandall","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.arr.2018.10.005_bib0075","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0091-3057(03)00116-3","article-title":"Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones","volume":"75","author":"Duffy","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.arr.2018.10.005_bib0080","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1001\/jama.291.24.2959","article-title":"Conjugated equine estrogens and global cognitive function in postmenopausal women: women\u2019s Health Initiative Memory Study","volume":"291","author":"Espeland","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.arr.2018.10.005_bib0085","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jamainternmed.2013.7727","article-title":"Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years","volume":"173","author":"Espeland","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.arr.2018.10.005_bib0090","doi-asserted-by":"crossref","DOI":"10.3390\/nu9010027","article-title":"Effects of resveratrol on cognitive performance, mood and cerebrovascular function in post-menopausal women; a 14-week randomised placebo-controlled intervention trial","volume":"9","author":"Evans","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.arr.2018.10.005_bib0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/13697137.2015.1020484","article-title":"Long-term health consequences of premature or early menopause and considerations for management","volume":"18","author":"Faubion","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.arr.2018.10.005_bib0100","first-page":"57700","article-title":"Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS","volume":"64","author":"Food and Drug Administration","year":"1999","journal-title":"Final rule. Federal register"},{"key":"10.1016\/j.arr.2018.10.005_bib0105","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1001\/jama.2017.16952","article-title":"Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: evidence report and systematic review for the US preventive services task force","volume":"318","author":"Gartlehner","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.arr.2018.10.005_bib0110","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/HYPERTENSIONAHA.107.106526","article-title":"Menopausal complaints are associated with cardiovascular risk factors","volume":"51","author":"Gast","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.arr.2018.10.005_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001833","article-title":"Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-Cognitive and affective study","volume":"12","author":"Gleason","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.arr.2018.10.005_bib0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/13697137.2012.669584","article-title":"Micronized progesterone and its impact on the endometrium and breast vs. progestogens","volume":"15","author":"Gompel","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.arr.2018.10.005_bib0125","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7326\/0003-4819-133-12-200012190-00008","article-title":"A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease","volume":"133","author":"Grodstein","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.arr.2018.10.005_bib0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/M14-0353","article-title":"Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial","volume":"161","author":"Harman","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.arr.2018.10.005_bib0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archinte.1991.00400010095012","article-title":"Decreased mortality in users of estrogen replacement therapy","volume":"151","author":"Henderson","year":"1991","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.arr.2018.10.005_bib0140","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1212\/WNL.0000000000002980","article-title":"Cognitive effects of estradiol after menopause: a randomized trial of the timing hypothesis","volume":"87","author":"Henderson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2018.10.005_bib0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of postmenopausal hormone therapy: annual trends and response to recent evidence","volume":"291","author":"Hersh","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.arr.2018.10.005_bib0150","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1161\/STROKEAHA.111.620831","article-title":"Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial","volume":"42","author":"Hodis","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.arr.2018.10.005_bib0155","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"Vascular effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2018.10.005_bib0160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2012.12.009","article-title":"Phytoestrogens and the metabolic syndrome","volume":"139","author":"Jungbauer","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.arr.2018.10.005_bib0165","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3233\/JAD-160258","article-title":"Early postmenopausal transdermal 17beta-Estradiol therapy and amyloid-beta deposition","volume":"53","author":"Kantarci","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2018.10.005_bib0170","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00042192-200310030-00004","article-title":"Isoflavones and cognitive function in older women: the SOy and postmenopausal health in aging (SOPHIA) study","volume":"10","author":"Kritz-Silverstein","year":"2003","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1016\/j.arr.2018.10.005_bib0175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/13697137.2013.808563","article-title":"HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT","volume":"16","author":"L\u2019Hermite","year":"2013","journal-title":"Climacteric"},{"key":"10.1016\/j.arr.2018.10.005_bib0180","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial","volume":"305","author":"LaCroix","year":"2011","journal-title":"Jama"},{"key":"10.1016\/j.arr.2018.10.005_bib0185","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/gme.0b013e3182175e5c","article-title":"Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy","volume":"18","author":"Lalibert\u00e9","year":"2011","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1016\/j.arr.2018.10.005_bib0190","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/13697137.2017.1362156","article-title":"Menopausal hormone therapy for primary prevention: why the USPSTF is wrong","volume":"20","author":"Langer","year":"2017","journal-title":"Climacteric"},{"key":"10.1016\/j.arr.2018.10.005_bib0195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clnu.2007.10.012","article-title":"Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials","volume":"27","author":"Ma","year":"2008","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.arr.2018.10.005_bib0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.gme.0000191204.38664.61","article-title":"Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study","volume":"13","author":"MacLennan","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.arr.2018.10.005_bib0205","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/gme.0b013e3181ace484","article-title":"Effects of botanicals and combined hormone therapy on cognition in postmenopausal women","volume":"16","author":"Maki","year":"2009","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1016\/j.arr.2018.10.005_bib0210","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women\u2019s health initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.arr.2018.10.005_bib0215","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women\u2019s Health Initiative randomized trials","volume":"318","author":"Manson","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.arr.2018.10.005_bib0220","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1161\/CIRCULATIONAHA.108.809491","article-title":"Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial","volume":"119","author":"Maruthur","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.arr.2018.10.005_bib0225","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/GME.0000000000000450","article-title":"Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality","volume":"22","author":"Mikkola","year":"2015","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1016\/j.arr.2018.10.005_bib0230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-158-1-201301010-00553","article-title":"Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive services task force recommendation statement","volume":"158","author":"Moyer","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.arr.2018.10.005_bib0235","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/13697137.2014.975199","article-title":"The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy","volume":"18","author":"Nappi","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.arr.2018.10.005_bib0240","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","article-title":"The 2012 hormone therapy position statement of the North American Menopause Society","volume":"19","author":"North American Menopause Society","year":"2012","journal-title":"Menopause (New York, NY)"},{"key":"10.1016\/j.arr.2018.10.005_bib0245","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/GME.0000000000000546","article-title":"Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of the North American Menopause Society","volume":"22","author":"North American Menopause Society","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.arr.2018.10.005_bib0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2008.08.001","article-title":"Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis","volume":"138","author":"Petretta","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.arr.2018.10.005_bib0255","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1089\/jwh.2016.6151","article-title":"The effect of transdermal estrogen patch use on cardiovascular outcomes: a systematic review","volume":"26","author":"Prema","year":"2017","journal-title":"J. Womens Health"},{"key":"10.1016\/j.arr.2018.10.005_bib0260","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1001\/jama.289.20.2663","article-title":"Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women\u2019s Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Rapp","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.arr.2018.10.005_bib0265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.AOG.0000222383.43913.ed","article-title":"Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial","volume":"108","author":"Reddy","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.arr.2018.10.005_bib0270","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1191\/1740774504cn040oa","article-title":"The Women\u2019s Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline","volume":"1","author":"Resnick","year":"2004","journal-title":"Clin. Trials"},{"key":"10.1016\/j.arr.2018.10.005_bib0275","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2005-2097","article-title":"Effects of combination estrogen plus progestin hormone treatment on cognition and affect","volume":"91","author":"Resnick","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.arr.2018.10.005_bib0280","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1210\/jc.2009-1340","article-title":"Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy","volume":"94","author":"Resnick","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.arr.2018.10.005_bib0285","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast Cancer risk: estrogen versus estrogen plus progestin","volume":"92","author":"Ross","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.arr.2018.10.005_bib0290","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing Group for the Women\u2019s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2018.10.005_bib0295","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"Jama"},{"key":"10.1016\/j.arr.2018.10.005_bib0300","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2105\/AJPH.2013.301295","article-title":"The mortality toll of estrogen avoidance: an analysis of excess deaths among hysterectomized women aged 50 to 59 years","volume":"103","author":"Sarrel","year":"2013","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.arr.2018.10.005_bib0305","first-page":"345","article-title":"Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial","author":"Schierbeck","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.arr.2018.10.005_bib0310","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0197-2456(98)00038-5","article-title":"The women\u2019s health initiative memory study (WHIMS)","volume":"19","author":"Shumaker","year":"1998","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.arr.2018.10.005_bib0315","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women\u2019s Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Shumaker","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.arr.2018.10.005_bib0320","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: women\u2019s Health Initiative Memory Study","volume":"291","author":"Shumaker","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.arr.2018.10.005_bib0325","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.maturitas.2009.08.003","article-title":"Premature menopause or early menopause: long-term health consequences","volume":"65","author":"Shuster","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.arr.2018.10.005_bib0330","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.yhbeh.2012.06.003","article-title":"Progesterone and neuroprotection","volume":"63","author":"Singh","year":"2013","journal-title":"Horm. Behav."},{"key":"10.1016\/j.arr.2018.10.005_bib0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamainternmed.2013.11074","article-title":"Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens","volume":"174","author":"Smith","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.arr.2018.10.005_bib0340","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsbmb.2015.10.024","article-title":"Phytoestrogen consumption and risk for cognitive decline and dementia: with consideration of thyroid status and other possible mediators","volume":"160","author":"Soni","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.arr.2018.10.005_bib0345","series-title":"American Journal of Epidemiology","article-title":"A sustained decline in postmenopausal hormone use: results from NHANES 1999-2010","author":"Sprague","year":"2012"},{"key":"10.1016\/j.arr.2018.10.005_bib0350","first-page":"272","article-title":"Do SSRIs and SNRIs reduce the frequency and\/or severity of hot flashes in menopausal women","volume":"110","author":"Stubbs","year":"2017","journal-title":"J. Okla. State Med. Assoc."},{"key":"10.1016\/j.arr.2018.10.005_bib0355","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/nyas.13459","article-title":"Does phytoestrogen supplementation improve cognition in humans? A systematic review","volume":"1403","author":"Thaung Zaw","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.arr.2018.10.005_bib0360","first-page":"728","article-title":"Hormone Therapy Position Statement Advisory Panel, 2017. The 2017 hormone therapy position statement of The North American Menopause Society","volume":"24","author":"NAMS","year":"2017","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1016\/j.arr.2018.10.005_bib0365","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/GME.0000000000000481","article-title":"Menopausal hot flashes and white matter hyperintensities","volume":"23","author":"Thurston","year":"2016","journal-title":"Menopause"},{"key":"10.1016\/j.arr.2018.10.005_bib0370","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/13697137.2012.709889","article-title":"Stellate-ganglion block as a treatment for severe postmenopausal flushing","volume":"16","author":"van Gastel","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.arr.2018.10.005_bib0375","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/GME.0000000000000194","article-title":"Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized, controlled clinical trial in postmenopausal women","volume":"21","author":"Walega","year":"2014","journal-title":"Menopause (New York, NY)"},{"key":"10.1016\/j.arr.2018.10.005_bib0380","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2013.04.011","article-title":"Rationale and design of the kronos early estrogen prevention study (KEEPS) and the KEEPS cognitive and affective sub study (KEEPS cog)","volume":"1514","author":"Wharton","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2018.10.005_bib0385","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.0385-14.2014","article-title":"Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults","volume":"34","author":"Witte","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2018.10.005_bib0390","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/nu8070425","article-title":"Acute resveratrol consumption improves neurovascular coupling capacity in adults with type 2 diabetes mellitus","volume":"8","author":"Wong","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.arr.2018.10.005_bib0395","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/GME.0000000000000861","article-title":"Resveratrol supplementation reduces pain experience by postmenopausal women","volume":"24","author":"Wong","year":"2017","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1016\/j.arr.2018.10.005_bib0400","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.maturitas.2013.11.007","article-title":"The association between vasomotor symptoms and depression during perimenopause: a systematic review","volume":"77","author":"Worsley","year":"2014","journal-title":"Maturitas"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163718301612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163718301612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:39:37Z","timestamp":1761590377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163718301612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":80,"alternative-id":["S1568163718301612"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2018.10.005","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postmenopausal health interventions: Time to move on from the Women\u2019s Health Initiative?","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2018.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}